Julian Müller-Kühnle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julian Müller-Kühnle has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Joerg Latus
Department of Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Auerbachstr. 110, 70376 Stuttgart, Germany
3 shared publications - Moritz Schanz
Department of Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Auerbachstr. 110, 70376 Stuttgart, Germany
3 shared publications - Severin Schricker
Department of Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Auerbachstr. 110, 70376 Stuttgart, Germany
3 shared publications - Dominik Marschner
Department of Internal Medicine I, Universitätsklinikum Freiburg (University Medical Center Freiburg), Freiburg, Germany
2 shared publications Jörg Latus
Abteilung für Allgemeine Innere Medizin und Nephrologie, Robert Bosch Krankenhaus, Auerbachstr. 110, 70376, Stuttgart, Deutschland
2 shared publicationsMoritz Schanz
Abteilung für Allgemeine Innere Medizin und Nephrologie, Robert Bosch Krankenhaus, Auerbachstr. 110, 70376, Stuttgart, Deutschland
2 shared publications
Latest Publications
- Open Access
- 14 July 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Chronic Pruritus in Predialysis Chronic Kidney Disease: Prevalence, Phenotype and Temporal Patterns in a Prospective Cohort.
CKD-associated pruritus (CKD-aP) is a burden some symptom with incompletely understood pathophysiology and limited predialysis data. In this prospective observational study, 95 adult nondialysis CKD patients (stages G1-G5) were followed for up to 36 months (232 observations), 86 patients were analysed after exclusion of chronic dermatological conditions. Chronic pruritus (≥6 weeks) was assessed using a numerical rating scale (NRS) and anatomical mapping. Chronic pruritus occurred in 26 of 86 patients (30.2%), with numerically higher prevalence in advanced CKD (G3b-5 : 32.8% vs G1-3a: 22.7%), whereas intensity was numerically higher in early CKD (median 8 vs 5). The back, legs and head/ face were most frequently affected, consistent with the bilateral, nondermatomal pattern described in dialysis populations. Among patients with repeated assessments, 19.0% showed an episodic trajectory and 7.6% had persistent pruritus. Multivariable logistic regression and generalized estimating equations (GEE) were used to identify independent predictors of chronic pruritus. No laboratory parameter, including PTH, was independently associated with pruritus. Dyslipidaemia was the only clinical characteristic significantly associated with pruritus status (69.2% vs 43.3%, p=0.035). Given the modest sample size, smaller effect estimates may have been missed. CKD-aP affects approximately 1 in 3 predialysis patients, follows an episodic course, and is not explained by any single biochemical marker, supporting multifactorial pathophysiology.
- 14 July 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Open AccessChronic Pruritus in Predialysis Chronic Kidney Disease: Prevalence, Phenotype and Temporal Patterns in a Prospective Cohort.
CKD-associated pruritus (CKD-aP) is a burden some symptom with incompletely understood pathophysiology and limited predialysis data. In this prospective observational study, 95 adult nondialysis CKD patients (stages G1-G5) were followed for up to 36 months (232 observations), 86 patients were analysed after exclusion of chronic dermatological conditions. Chronic pruritus (≥6 weeks) was assessed using a numerical rating scale (NRS) and anatomical mapping. Chronic pruritus occurred in 26 of 86 patients (30.2%), with numerically higher prevalence in advanced CKD (G3b-5 : 32.8% vs G1-3a: 22.7%), whereas intensity was numerically higher in early CKD (median 8 vs 5). The back, legs and head/ face were most frequently affected, consistent with the bilateral, nondermatomal pattern described in dialysis populations. Among patients with repeated assessments, 19.0% showed an episodic trajectory and 7.6% had persistent pruritus. Multivariable logistic regression and generalized estimating equations (GEE) were used to identify independent predictors of chronic pruritus. No laboratory parameter, including PTH, was independently associated with pruritus. Dyslipidaemia was the only clinical characteristic significantly associated with pruritus status (69.2% vs 43.3%, p=0.035). Given the modest sample size, smaller effect estimates may have been missed. CKD-aP affects approximately 1 in 3 predialysis patients, follows an episodic course, and is not explained by any single biochemical marker, supporting multifactorial pathophysiology.
- 30 March 2026
- Published by Springer Nature in Die Innere Medizin
Extrapulmonale Sarkoidose mit Multiorganbeteiligung: ein komplexer Fall mit renaler, neurologischer und gastrointestinaler Manifestation
Systemic sarcoidosis can occur without pulmonary involvement and may present exclusively with extrapulmonary manifestations, thereby mimicking infections, autoimmune diseases, or malignancies. The case of a 60-year-old female patient with pronounced cachexia (BMI 14 kg/m2), hypercalcemia, and multiorgan involvement is presented. Histology revealed non-caseating granulomas in gastric biopsies (granulomatous gastritis) as well as granulomatous interstitial nephritis with a tubular proteinuria pattern on renal biopsy. Imaging revealed no evidence of pulmonary involvement. Markedly elevated serum angiotensin-converting enzyme and soluble interleukin‑2 receptor levels, together with cerebrospinal fluid and MRI findings, were consistent with neurosarcoidosis. As the disease progressed, posterior reversible encephalopathy syndrome developed, presenting with seizures and transient cortical blindness. An extensive differential diagnostic workup, particularly for lymphoma, tuberculosis, and systemic vasculitis, was negative. The clinical course was complicated by percutaneous endoscopic gastrostomy-associated Enterococcus faecium peritonitis and Candida albicans sepsis. After stabilization and infection control, high-dose corticosteroid therapy was initiated, resulting in partial improvement of renal function and neurological symptoms. This case highlights the diagnostic and therapeutic challenges of life-threatening, purely extrapulmonary sarcoidosis with renal, gastrointestinal, and neurological manifestations. Early histological confirmation, thorough exclusion of relevant differential diagnoses, and multidisciplinary management are essential, particularly in balancing immunosuppression with infection control.
- 30 March 2026
- Published by Springer Nature in Die Innere Medizin
Extrapulmonale Sarkoidose mit Multiorganbeteiligung: ein komplexer Fall mit renaler, neurologischer und gastrointestinaler Manifestation
Systemic sarcoidosis can occur without pulmonary involvement and may present exclusively with extrapulmonary manifestations, thereby mimicking infections, autoimmune diseases, or malignancies. The case of a 60-year-old female patient with pronounced cachexia (BMI 14 kg/m2), hypercalcemia, and multiorgan involvement is presented. Histology revealed non-caseating granulomas in gastric biopsies (granulomatous gastritis) as well as granulomatous interstitial nephritis with a tubular proteinuria pattern on renal biopsy. Imaging revealed no evidence of pulmonary involvement. Markedly elevated serum angiotensin-converting enzyme and soluble interleukin‑2 receptor levels, together with cerebrospinal fluid and MRI findings, were consistent with neurosarcoidosis. As the disease progressed, posterior reversible encephalopathy syndrome developed, presenting with seizures and transient cortical blindness. An extensive differential diagnostic workup, particularly for lymphoma, tuberculosis, and systemic vasculitis, was negative. The clinical course was complicated by percutaneous endoscopic gastrostomy-associated Enterococcus faecium peritonitis and Candida albicans sepsis. After stabilization and infection control, high-dose corticosteroid therapy was initiated, resulting in partial improvement of renal function and neurological symptoms. This case highlights the diagnostic and therapeutic challenges of life-threatening, purely extrapulmonary sarcoidosis with renal, gastrointestinal, and neurological manifestations. Early histological confirmation, thorough exclusion of relevant differential diagnoses, and multidisciplinary management are essential, particularly in balancing immunosuppression with infection control.
- Open Access
- 23 September 2025
- Published by Springer Nature in BMC Palliative Care
- Vol. 24 (1) , 1-10
Life after hepatorenal syndrome: unraveling quality of life, psychological distress, and treatment preferences
Hepatorenal syndrome (HRS) is a life-threatening complication of advanced liver disease, associated with high short-term mortality and persistent symptom burden among survivors. While therapeutic advances have improved survival, little is known about the long-term quality of life (QoL), psychological distress, symptom management, and care preferences in this vulnerable population. In this prospective mixed-methods study, conducted between September 2024 and March 2025 at Robert Bosch Hospital in Stuttgart, Germany, patients who survived an HRS episode between 2019 and 2024 were identified retrospectively and invited for structured surveys. Patient-reported outcomes were assessed using the Short Form-12 (SF-12), targeted symptom and psychosocial questionnaires, and preference-oriented items. Quantitative data were analyzed descriptively and comparatively; open-ended responses were evaluated using qualitative content analysis. Fifteen HRS survivors (mean age 62 ± 13 years; 33% male; 73% with alcohol-related cirrhosis) participated. Mean scores on the physical component summary (PCS-12) and mental component summary (MCS-12) of the SF-12 were 42.6 ± 8.5 and 41.7 ± 7.4, respectively, indicating moderate impairment in physical and mental health. Fatigue (73%), fluid retention (53%), and dyspnea (47%) were the most frequently reported symptoms. Psychological distress was reported by 87% of patients, and 53% expressed substantial fear of rehospitalization. Treatment preferences varied: 53% favored intensive care in case of deterioration, 7% preferred a palliative approach, and 40% remained undecided. Survivors of HRS face considerable long-term impairments and psychosocial vulnerability. These findings underscore the need for structured multidisciplinary follow-up that integrates symptom relief, psychological support, and individualized decision-making. Given the exploratory nature and small sample size, further longitudinal studies are needed to confirm these findings and inform targeted supportive care strategies.
- 23 September 2025
- Published by Springer Nature in BMC Palliative Care
- Vol. 24 (1) , 1-10
Open AccessLife after hepatorenal syndrome: unraveling quality of life, psychological distress, and treatment preferences
Hepatorenal syndrome (HRS) is a life-threatening complication of advanced liver disease, associated with high short-term mortality and persistent symptom burden among survivors. While therapeutic advances have improved survival, little is known about the long-term quality of life (QoL), psychological distress, symptom management, and care preferences in this vulnerable population. In this prospective mixed-methods study, conducted between September 2024 and March 2025 at Robert Bosch Hospital in Stuttgart, Germany, patients who survived an HRS episode between 2019 and 2024 were identified retrospectively and invited for structured surveys. Patient-reported outcomes were assessed using the Short Form-12 (SF-12), targeted symptom and psychosocial questionnaires, and preference-oriented items. Quantitative data were analyzed descriptively and comparatively; open-ended responses were evaluated using qualitative content analysis. Fifteen HRS survivors (mean age 62 ± 13 years; 33% male; 73% with alcohol-related cirrhosis) participated. Mean scores on the physical component summary (PCS-12) and mental component summary (MCS-12) of the SF-12 were 42.6 ± 8.5 and 41.7 ± 7.4, respectively, indicating moderate impairment in physical and mental health. Fatigue (73%), fluid retention (53%), and dyspnea (47%) were the most frequently reported symptoms. Psychological distress was reported by 87% of patients, and 53% expressed substantial fear of rehospitalization. Treatment preferences varied: 53% favored intensive care in case of deterioration, 7% preferred a palliative approach, and 40% remained undecided. Survivors of HRS face considerable long-term impairments and psychosocial vulnerability. These findings underscore the need for structured multidisciplinary follow-up that integrates symptom relief, psychological support, and individualized decision-making. Given the exploratory nature and small sample size, further longitudinal studies are needed to confirm these findings and inform targeted supportive care strategies.
- Open Access
- 17 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0332840
Predicting severe renal dysfunction in alcohol-associated cirrhosis: Comparative performance of liver function scores and machine learning models
Background: Renal dysfunction is a frequent and clinically relevant complication of cirrhosis, yet chronic kidney disease (CKD) often remains underrecognized, particularly in non-acute settings. Early identification of at-risk patients is essential to guide timely interventions. Although MELD, Child-Pugh Score (CPS), APRI, and FIB-4 are widely used to assess hepatic disease severity, their predictive value for advanced renal dysfunction is uncertain. Methods: In this retrospective cohort study (2014–2021, Klinikum Stuttgart), we evaluated the ability of MELD, CPS, APRI, and FIB-4 to predict severe renal dysfunction (chronic kidney disease [CKD] stage ≥ 3, according to Kidney Disease: Improving Global Outcomes [KDIGO] classification) in patients with alcoholic cirrhosis. Logistic and linear regression analyses were performed. In addition, machine learning (ML) models were trained to identify non-renal predictors of CKD stage ≥ 3. Results: Among 131 patients (mean age 62.8 ± 11.3 years; 71% male), 33% met criteria for KDIGO stage ≥ 3. MELD was significantly associated with advanced CKD (OR = 1.379, p < 0.001), with prevalence increasing from 17% (MELD ≤ 9) to 80% (MELD ≥ 20). CPS showed an inverse association (p = 0.002), while APRI and FIB-4 were not predictive. The optimized Random Forest model, refined through ROSE oversampling and feature selection, achieved an AUC of 0.757, with 76% accuracy, 82% sensitivity (KDIGO < 3), and 63% specificity (KDIGO ≥ 3). Conclusion: MELD was the most reliable conventional score for identifying advanced renal dysfunction in alcoholic cirrhosis. ML-based models incorporating routinely available clinical parameters further improved predictive performance and may support risk stratification in this high-risk population.
- 17 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0332840
Open AccessPredicting severe renal dysfunction in alcohol-associated cirrhosis: Comparative performance of liver function scores and machine learning models
Background: Renal dysfunction is a frequent and clinically relevant complication of cirrhosis, yet chronic kidney disease (CKD) often remains underrecognized, particularly in non-acute settings. Early identification of at-risk patients is essential to guide timely interventions. Although MELD, Child-Pugh Score (CPS), APRI, and FIB-4 are widely used to assess hepatic disease severity, their predictive value for advanced renal dysfunction is uncertain. Methods: In this retrospective cohort study (2014–2021, Klinikum Stuttgart), we evaluated the ability of MELD, CPS, APRI, and FIB-4 to predict severe renal dysfunction (chronic kidney disease [CKD] stage ≥ 3, according to Kidney Disease: Improving Global Outcomes [KDIGO] classification) in patients with alcoholic cirrhosis. Logistic and linear regression analyses were performed. In addition, machine learning (ML) models were trained to identify non-renal predictors of CKD stage ≥ 3. Results: Among 131 patients (mean age 62.8 ± 11.3 years; 71% male), 33% met criteria for KDIGO stage ≥ 3. MELD was significantly associated with advanced CKD (OR = 1.379, p < 0.001), with prevalence increasing from 17% (MELD ≤ 9) to 80% (MELD ≥ 20). CPS showed an inverse association (p = 0.002), while APRI and FIB-4 were not predictive. The optimized Random Forest model, refined through ROSE oversampling and feature selection, achieved an AUC of 0.757, with 76% accuracy, 82% sensitivity (KDIGO < 3), and 63% specificity (KDIGO ≥ 3). Conclusion: MELD was the most reliable conventional score for identifying advanced renal dysfunction in alcoholic cirrhosis. ML-based models incorporating routinely available clinical parameters further improved predictive performance and may support risk stratification in this high-risk population.
- Open Access
- 31 July 2025
- Published by Society of Gastrointestinal Intervention in International Journal of Gastrointestinal Intervention
- Vol. 14 (3) , 113-119
Validation of the EVendo score for assessing high-risk varices in Western European patients with cirrhosis
Julian Müller-Kühnle, Christian Benignus, Severin Schricker, Moritz Schanz, Julia Todoroff, Jörg Latus, Wolfram Zoller, and Dominik Marschner. Int J Gastrointest Interv 2025;14:113-9. https://doi.org/10.18528/ijgii240059
- 31 July 2025
- Published by Society of Gastrointestinal Intervention in International Journal of Gastrointestinal Intervention
- Vol. 14 (3) , 113-119
Open AccessValidation of the EVendo score for assessing high-risk varices in Western European patients with cirrhosis
Julian Müller-Kühnle, Christian Benignus, Severin Schricker, Moritz Schanz, Julia Todoroff, Jörg Latus, Wolfram Zoller, and Dominik Marschner. Int J Gastrointest Interv 2025;14:113-9. https://doi.org/10.18528/ijgii240059